Lv1
44 积分 2025-11-10 加入
Insights into the Mechanism of Action of Tirzepatide: A Narrative Review
2个月前
已完结
Tirzepatide and Cardiovascular Outcomes: A Narrative Review of Mechanisms, Efficacy and Implications for Heart Failure Management
2个月前
已完结
Effect of Tirzepatide on Cardiovascular Outcomes
2个月前
已完结
Antioxidants: Molecules, medicines, and myths
3个月前
已完结
Cardiovascular benefits of semaglutide: a systematic review and meta-analysis of randomized controlled trials
3个月前
已完结
Holistic View of Tirzepatide’s Role in Obesity-Related HFpEF
4个月前
已完结
Tirzepatide and the 10‐year predicted risk of cardiovascular disease and type 2 diabetes in adults with obesity and prediabetes: A post hoc analysis from the three‐year SURMOUNT ‐1 trial
4个月前
已完结
Tirzepatide Reduces LV Mass and Paracardiac Adipose Tissue in Obesity-Related Heart Failure
4个月前
已完结
Tirzepatide for reduction of morbidity and mortality in adults with obesity: rationale and design of the SURMOUNT‐MMO trial
4个月前
已完结
Tirzepatide versus insulin glargine in type 2 diabetes and increased cardiovascular risk (SURPASS-4): a randomised, open-label, parallel-group, multicentre, phase 3 trial
4个月前
已完结
皖公网安备34019202002308
